China, Aug. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Identification of Neoantigens and Immune Responses in Cervical Cancer Patients Receiving Concurrent Chemoradiotherapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129974
Registration Time: 2026/08/12
Type: Observational study
Primary Sponsor: Women’s Hospital, Zhejiang University School of Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=288016
Published by HT Digital Content Services with permission from Health Daily Digest....